In hematological tumors (multiple myeloma), LiCl triggers cell cycle arrest and apoptosis by inhibition of GSK3β and the activation of the Wnt/β-catenin signaling pathway [24]. The gene discussed is GSK3B; the disease is plasma cell myeloma.